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Abstract
Contagious bovine pleuropneumonia (CBPP), caused byMycoplasmamycoides subsp.
mycoides (Mmm), is a severe respiratory disease of cattle responsible for major economic
losses in sub-Saharan Africa. Disease control relies mainly on the use of empirically attenu-
ated vaccines that provide limited protection. Thus, understanding the virulence mechanisms
used byMmm as well as the role of the host immune system in disease development, persis-
tence, and control is a prerequisite for the development of new, rationally designed control
strategies. The aim of this study was to assess the use of whole blood transcriptome analysis
to study cattle-Mmm interactions, starting by the characterization of the bovine response to
Mmm infection during the acute form of the disease. For that purpose, we compared the tran-
scriptome profile of whole blood from six cattle, before challenge by contact withMmm-
infected animals and at the appearance of first clinical signs, using a bovine microarray. Func-
tional analysis revealed that 680 annotated genes were differentially expressed, with an over-
whelming majority of down-regulated genes characterizing an immunosuppression. Themain
bio-functions affected were “organismal survival”, “cellular development,morphology and
functions” and “cell-to cell signaling and interactions”. These affected functions were consis-
tent with the results of previous in vitro immunological studies. However, microarray and qPCR
validation results did not highlight pro-inflammatory molecules (such as TNFα, TLR2, IL-12B
and IL-6), whereas inflammation is one of the most characteristic traits of acute CBPP. This
global gene expression pattern may be considered as the result, in blood, of the local pulmo-
nary response and the systemic events occurring during acute CBPP. Nevertheless, to under-
stand the immune events occurring during disease, detailed analyses on the different immune
cell subpopulations, either in vivo, at the local site, or in vitro, will be required. Whole blood tran-
scriptome analysis remains an interesting approach for the identification of bio-signatures cor-
relating to recovery and protection, which should facilitate the evaluation and validation of
novel vaccine formulations.
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Introduction
Contagious bovine pleuropneumonia (CBPP) is an inflammatory respiratory disease caused by
Mycoplasma mycoides subsp.mycoides, previously known as “Small Colony” (Mmm) [1].
CBPP is a severe disease of cattle and is responsible for substantial economic losses in sub-
Saharan Africa. Given its impact on livestock production and its potential for spread, CBPP is
on the list of notifiable diseases of the World Organization for Animal Health (OIE) [2].
Bovids and water buffaloes are the only natural hosts of concern here, and the disease is
only transmitted by direct contact with infected animals.Mmm shows a strict tropism to the
thoracic cavity, where it induces a severe inflammatory reaction characterized by serofibrinous
pleurisy and interstitial pneumonia, whereby lesions typically affect only one lung [3]. This
classical disease presentation is observed in the acute form of the disease, whenMmm infects
naïve populations, and results in a high mortality rate. However, some animals may gradually
recover, acting as asymptomatic carriers and excreting the etiologic agent for many months.
The sub-acute and chronic forms are less conspicuous and are characterized by the presence of
pleural adhesions and encapsulated necrotic lesions, known as “sequestra”.
CBPP is enzootic in African countries, and control relies mainly on vaccination. Unfortu-
nately, the current vaccine strain T1/44 is not optimally efficient, since it confers only partial,
transient protection and may provoke side effects due to residual virulence [4]. The strain has
been attenuated empirically, and the molecular basis of attenuation is unknown. In this con-
text, understanding the mechanisms behindMmm virulence as well as the role of the host
immune system in disease development, persistence, and control is a prerequisite for the devel-
opment of novel, rationally designed vaccines.
So far, no classical virulence factors such as adhesins or toxins have been identified in the
Mmm genome [5] and virulence has been attributed to surface or secreted components and
intrinsic metabolic functions. In particular, the release of hydrogen peroxide through glycerol
metabolism resulting in cellular damage and inflammation, has been proposed as a major viru-
lence factor [6], while capsular and secreted exopolysaccharide (galactan) have been suggested
to be involved in disease exacerbation and persistence by enabling resistance to host defenses
[7]. In vitro immunological studies showed that viableMmm is able to induce programed cell
death in bovine blood leukocytes [8] and to depress bovine cell responsiveness to the mitogen
Concanavalin A [9], suggesting thatMmm has developed mechanisms to prevent its direct
elimination by the host immune system.
Mmm-specific IFNγ producing memory CD4+ T cells have been correlated with disease
recovery, suggesting a role for this response in protection [10,11,12,13,14], though Sacchini
et al reported only a minor role for CD4+ lymphocytes in the control of primaryMmm infec-
tion [15]. A better assessment of the protective immune mechanisms that prevent clinical dis-
ease may be obtained through a comprehensive, dynamic characterization of the host response
during acute and chronic disease, recovery and protection, using high-throughput genome-
wide transcriptomics. Blood is easy to obtain from animals, without the need for slaughter, and
previous studies have shown that immune responses detected in blood reflect those at the site
of infection [16]. The aim of this study was thus to assess the use of whole blood transcriptome
analysis to study host-pathogen interactions in CBPP. In this first study, this type of analysis
was used to characterize the bovine response toMmm infection in the acute form of the
disease.
The analysis of global gene expression in blood was shown to be an interesting, non-invasive
approach to study bovine-mycoplasma interactions. This preliminary analysis provided a
global picture of the circulating response in blood during acute CBPP but it did not reflect the
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local inflammatory disease. Still, this approach may be applied to the identification of some of
the molecular mechanisms correlating to disease exacerbation or to recovery and protection
(bio-marker signatures), thus paving the way for the development of novel vaccine
formulations.
Material and Methods
Ethic statement
Scacchia et al. showed that only naturally infected cattle are relevant for immune studies on
CBPP, as opposed to animals infected by endotracheal intubation [17]. Studies on cattle must
therefore be performed under controlled conditions using animals infected by direct contact.
In the present study, the experiment was carried out with the permission of the VRCMuguga
Institutional Animal Care and Use Committee (IACUC), reference number KARI/VRC/
IACUC/2/00122010. Animals were euthanized if they showed fever for 10 days or were recum-
bent for 3 days. The rest of the animals, without these severe clinical signs, were killed at the
end of the experiment. Animals were sacrificed by stunning with a captive bolt, followed by
exsanguination, in accordance with the ethical considerations of the VRCMuguga IACUC;
analgesics or anesthetics were not used.
Experimental design and sampling
The status of naïve zebus above three years of age was checked for the absence ofMmm-specific
antibodies using the cELISA “Mmm antibody test kit” (IDEXX, Montpellier, France), a method
for CBPP serodiagnosis prescribed by the OIE. To guarantee the natural mode of transmission,
10 naïve animals were put in contact with 20 cattle previously infected withMmm (strain
B237) by the endobronchial route. Clinical signs (i.e. fever and cough, at rest or following
effort) were checked daily. Following ethical principles, animals that developed severe clinical
signs were humanely slaughtered before the end of the experiment.
Sera were collected at regular intervals from the beginning of the trial until slaughter.
Mmm-specific antibody responses were assessed using the CBPP cELISA twice before contact
(10 and 2 weeks before contact), and then monthly after contact until the day of slaughter,
using the CBPP cELISA according to the manufacturer’s instructions.
For transcriptome analyses, the first blood sample was collected from all animals 10 weeks
before the introduction of infected cattle. Thereafter, blood was sampled from six cattle at the
appearance of CBPP clinical signs, which took place 10 to 11 weeks after contact. TempusTM
blood RNA collecting tubes (Applied Biosystems Ltd., Warrington, UK) were used according
to manufacturer’s instructions. Briefly, 3 ml of blood was collected from the jugular vein into a
TempusTM tube, and then stored in Kenya at -20°C until shipment at the end of the experimen-
tal trial. Samples were transported in refrigerated boxes and stored at -80°C for several weeks
until processing using TempusTM technology and quality control tools.
Necropsy was performed on all animals at slaughter. The presence, type, and size of the pul-
monary lesions were recorded.
RNA extraction and preparation and microarray hybridization
All Tempus samples were treated separately, at the same time. Total RNA was extracted using
the TempusTM Spin RNA Isolation Reagent Kit (Applied Biosystems Ltd., Warrington, UK)
according to the manufacturer’s instructions, including optional DNAse treatment. RNA sam-
ples were stored at -80°C in multiple aliquots to avoid repeated freeze-thaw cycles. An aliquot
of each RNA sample was used to assess RNA yield and quality, using a Nanodrop™ND-1000
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Spectrophotometer (Thermo Fisher Scientific, MA, USA). RNA quality was further assessed
using the Agilent 2100 Bioanalyzer platform (Agilent Technologies, Inc. Santa Clara, USA). All
the RNA samples were satisfactory, both in terms of quantity and quality, for transcriptome
analysis using micro-array technology. We collected 14.8 ± 2.5 μg RNA, with an RNA integrity
number (RIN) of 6.9 ± 0.4 from non-infected animals and 7.4 ± 2.6 μg RNA with a RIN of
8.5 ± 0.1 from infected animals.
To produce Cy3-labeled cRNA, each total RNA sample was amplified and labeled using the
Agilent Low Input Quick Amplification Labeling Kit, v6.5, (available online: http://www.chem.
agilent.com/library/usermanuals/) strictly following the manufacturer’s instructions. All sam-
ples were processed in the same manner within a week interval (Four animals first then the
remaining two). Briefly, 50 ng of template RNAs were used for cDNA synthesis. T7 RNA poly-
merase was then used for cRNA amplification and Cy3 labeling. After purification, yield and
dye incorporation were measured using a Nanodrop spectrophotometer. A total of 1.65 μg of
at least 6 pmol Cy3/ng of each RNA sample was fragmented using the Agilent Gene Expression
Hybridization Kit. Sample hybridizations were performed on an Agilent Bovine (V2) Gene
Expression Microarray for 17 h at 65°C. After gentle washing, according to Agilent’s protocol,
microarrays were scanned on a C scanner (Agilent). Agilent Feature Extraction software
(v10.7) was used to read out and process the microarray image files. The software determined
feature intensities and background, rejected outliers, and generated validated data files for fur-
ther analyses. Validation of each array consisted in the analysis of additive error, spatial distri-
bution of outliers on the array, histogram of signal plots, background sub-signal value and
linear range spike-in statistics. All assays were satisfactory for these parameters.
Microarray data normalization and analysis
All validated scan data files were processed using the Agilent GeneSpring GX (v11.5.1) software
for normalization with the 75 percentile model, with baseline transformation based on the
median of all samples. All entities with flag values present in at least 100% of the values in any
one out of the two status conditions (non-infected versus infected) were considered. Statistical
analysis (paired t-test) using the volcano plot filter was used to generate a unique list of up- or
down-regulated entities with associated Benjamini Hochberg False Discovery Rate corrected p-
value and fold change (FC) and for hierarchical clustering.
Using Ingenuity Pathway Analysis (IPA) software, differentially expressed entities were sepa-
rated into unmapped and mapped entities. A deduplication exercise on mapped entities resulted
in a final list of unique identified genes (p-value< 0.05 and absolute fold change 2), which was
then used to perform IPA bio-function analysis. IPA categorized and subcategorized modulated
genes according to p-values (calculated by the Fisher exact test) and z-scores. The z-score predicts
the direction of change of a function: a function is increased when z-score is 2 and decreased
when z-score 2. IPA calculated a bias-corrected z-score to correct dataset bias (i.e. when there
are more up- than down-regulated genes in a bio-function or vice-versa).
Quantitative PCR
Six genes were selected for the validation of the microarray results by quantitative reverse tran-
cription-PCR (RT-qPCR) analysis: two down-regulated genes (CD28 and SMAD-5) and four
statistically up-regulated genes (IL-1RN, IL-10RA, MyD88, and CXCR2). Four non-modulated
genes involved in inflammatory response or pathogen recognition (TLR-2, IL12-B, IL-6 and
TNFα) were also tested by RT-qPCR.
In addition, reference genes required for the normalization were determined in all samples
as described by Puech [18]. Briefly, the gene expression stability of five reference genes (ACTB,
Blood Transcriptome of Mmm-Infected Cattle
PLOS ONE | DOI:10.1371/journal.pone.0139678 October 2, 2015 4 / 18
GAPDH, H3F3A, PPIA, and YWHAZ) was determined and calculated using the geNorm anal-
ysis [19]. Two reference genes were required (V-value = 0.14) and the two most stable reference
genes were GAPDH and ACTB (M-value = 0.844 and 0.883, respectively).
The validation of microarray results was performed using the Cow RT2 qPCR assay (Qiagen,
Crawley, UK). RT-qPCR was performed with the same RNA samples used for microarray hybridi-
zations. Briefly, 400 nanograms of total RNA from each sample were reverse-transcribed with the
RT² First Strand Kit, including genomic DNA elimination step, and according to Qiagen’s instruc-
tions. In addition, RNA quality control was checked using Cow RT² RNAQC PCRArray (Qiagen),
which proved the efficiency of reverse transcription and the absence of genomic DNA contamina-
tion in all samples. QPCR reactions were conducted onMx3005P QPCR Systems™ (Agilent Tech-
nologies, Santa Clara, USA). Amplifications were performed with RT² SYBR Green ROXTM qPCR
Mastermix and using RT2 qPCR primers (Qiagen). Primer pairs were selected on the same gene
sequences (same GenBank accession numbers) as microarray probes (Table 1). The PCR thermal
cycling program consisted in one step at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s
and 60°C for 1 min, and a final dissociation step, which confirmed single specific PCR product
amplifications. A negative control (no-template control) was included in each primer assay.
FC of expression levels between infected and control groups were calculated using the rela-
tive expression software tool (REST) [20]. Correlation between the microarray and RT-qPCR
results for the six regulated genes was performed by the Pearson’s correlation calculation
(www.socscistatistics.com/tests/pearson/) and the statistical significance of the correlations was
determined. For microarray results, the data input in the correlation analysis was the absolute
FC value for each gene (S1 Table). For RT-qPCR, the normalized expression results calculated
by REST were used.
Results
Serological and post-mortem analyses show efficient CBPP
transmission
Ten naive zebus above three years of age were put in contact withMmm-infected cattle to
ensure natural transmission. Clinical signs were checked daily and six cattle showing typical
CBPP signs at approximately the same time were chosen for whole blood transcriptome analy-
sis. The experimental protocol is outlined in Fig 1.
According to CBPP cELISA results, all six animals were seropositive after nine to nineteen
weeks of contact withMmm-infected animals. Four of them became seropositive after the
Table 1. qPCR andmicroarray GeneBank accession numbers and Fold Changes of tested genes.
Gene GenBank accession number FC Array FC REST normalised
CD28 NM_181004.1 -2.72 -1.653
IL-1RN NM_174357.3 3.058 1.325
IL-10RA NM_001205757.1 2.923 1.094
MyD88 NM_001014382.2 3.202 1.391
CXCR2 NM_001101285.1 4.06 1.473
SMAD5 NM_001077107.2 -5.243 -1.587
TNFα NM_173966.3 - -1.31
TLR2 NM_174197.2 - -1.19
IL-12B NM_174356.1 - 1.386
IL-6 NM_173923.2 - -2.32
Bold = p-value<0.05;
doi:10.1371/journal.pone.0139678.t001
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beginning of the clinical signs, when the second blood sample for transcriptome analysis was
collected. The in-contact exposure route, less controlled than the intra-tracheal inoculation for
experimental challenge, still allowed us to obtain six animals showing clinical signs at approxi-
mately the same time. All animals showed clinical signs after two and a half months of contact
withMmm-infected cattle: 10 weeks for animals 724, 727 and 732 and 11 weeks for animals
747, 757 and 764 (Fig 1). Animals 724, 727, 732 and 757 were euthanized before the end of the
experiment, due to severe clinical signs, whereas animals 747 and 764 were euthanized at the
end of the experiment, after 5 months of contact withMmm-infected cattle. Post-mortem anal-
ysis showed that all the animals presented lesions considered characteristic of acute CBPP,
with lesions more than 20 cm in size for animals 724, 727, 732 and 764, and smaller lesions for
animals 747 (9x12cm) and 757 (12x16cm).
Cluster analysis shows a clear distinction between expression profiles of
Mmm-infected and non-infected animals
We investigated gene expression in the whole blood of six cattle before and after contact with
Mmm-infected cattle, using an Agilent Bovine Gene Expression Microarray, containing 43,654
Fig 1. Experimental protocol and cELISA CBPP kinetics.Healthy zebus were put in contact withMmm-infected cattle (time = 0).Mmm-specific antibody
responses were assessed twice before contact, monthly after contact, and on the day of slaughter, using the CBPP cELISA test (IDEXX, Montpellier,
France). The seropositivity threshold, defined by inhibition percentage values > 50%, is represented by the red horizontal line. For transcriptome analyses,
blood samples were collected before the introduction of infected cattle (①, time = -10 weeks) and subsequently, blood was sampled from six newly infected
zebus when CBPP clinical signs appeared (②, time = 10 weeks for 724, 727 and 732 and 11 weeks for animals 747, 757 and 764). ° Animal euthanized
because of severe clinical signs. * Animal slaughtered at the end of the experiment.
doi:10.1371/journal.pone.0139678.g001
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probes (entities) and representing 35,028 annotated genes. Results of a GeneSpring paired t-
test revealed that 1,115 entities (2.5% of probes) were significantly differentially expressed
(absolute fold change 2, with a Benjamini Hochberg False Discovery Rate corrected p-
value 0.05).
A notable feature was a higher proportion of down-regulated (947, i.e. 84.9%) than up-regu-
lated entities (168, i.e. 15.1%).
Hierarchical cluster analysis using the GeneSpring algorithm combined with the Euclidian
similarity measure and centroid linkage rule on non-averaged status produced a combined
dendrogram showing a clear distinction between the expression profiles of non-infected and
infected animals (Fig 2). All microarray data can be downloaded from NCBI’s Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) with the GEO series accession number
GSE70059.
It must be noted that there was no evidence of differential response between the four ani-
mals that had to be sacrificed before the end of the experiment and the two animals that sur-
vived until the end, although it was not possible to perform a statistical analysis with such a
small number of animals.
Differential gene expression analysis identifies affected immune bio-
functions inMmm-infected animals
To better understand the biological significance of the modulated genes, we performed bio-
function analysis using IPA software. The 1,115 previously identified entities were separated
into 786 mapped entities and 329 unmapped entities. A deduplication exercise on mapped
entities resulted in a final list of 680 identified genes (S1 Table) of which 544 genes (i.e. 80%)
were down-regulated in infected cattle. The 680 differentially-expressed genes were categorized
and subcategorized according to their p-values and z-scores, revealing 10 most modulated top
functions related to immune response in the infected group (Fig 3). These 10 top functions
were subcategorized into bio-functions by IPA (Table 2).
Based on the number of regulated genes, the most affected top function was organismal sur-
vival, with up-regulation of the organismal death bio-function. A total of 151 genes corre-
sponding to this bio-function were modulated, with a p-value of 4.2 10−3 and a z-score of 6.3,
representing a significant increase in this category. Another affected death-related top function
was cell death and survival, with down-regulation of the cell survival bio-function, based on 86
modulated genes (p-value: 0.0189; z-score: -2.134).
As shown in Table 2, top functions related to cellular development,morphology and func-
tions were affected, especially in terms of decreasing immune cell quantity: hematopoietic pro-
genitor cell, erythroid progenitors,myeloid progenitors, lymphatic system cells and B-
lymphocytes. Function of lymphocytes and T-lymphocytes bio-functions were also decreased.
Other related immune top functions were increased byMmm infection, including immune cell
trafficking, cellular movements and cell-to cell signaling and interactions, with an increase in
related bio-functions including chemotaxis of myeloid cells, chemotaxis of phagocytes, homing of
leukocytes and lymphocytes, recruitment of antigen presenting cells and activation of NK cells.
It is however important to note that inter-animal variability was observed for some differen-
tially-expressed genes, either in terms of magnitude or sometimes even in the direction of the
changes.
Quantitative PCR results correlate with microarray results
Validation of microarray results was performed using the Qiagen Cow RT² qPCR assay on a
set of six genes involved in immune bio-functions: four up-regulated genes (IL-1RN, IL-10RA,
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MyD88, CXCR2) and two down-regulated genes (CD28 and SMAD-5). Single specific melt
curves and no amplification in no-template controls confirmed the specificity of the RT-qPCR
assays.
Fig 2. Hierarchical combined tree.Hierarchical cluster dendrogram, grouped by GeneSpring according to the similarity in the expression of 1115entities.
Red lines represent increased mRNA level and blue lines represent decreased mRNA level, with Benjamini Hochberg False Discovery Rate corrected p-
value < 5 10−2 and absolute fold change 2.
doi:10.1371/journal.pone.0139678.g002
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The RT-qPCR results were strongly correlated with microarray results for these genes, with
a Pearson’s correlation coefficient of 0.973 (p-value = 0.00104). FC calculations, normalized
using GAPDH and ACTB as reference genes, confirmed that CD28 and SMAD-5 gene expres-
sion was down-regulated (p-value< 0.05), whereas the other four genes were up-regulated
(though with a p-value> 0.05).
Four additional genes specific for inflammation (TNFα, TLR2, IL-12B and IL-6), that were
not shown to be regulated by microarray analysis, were tested by RT-qPCR. Results confirmed
that they were not significantly regulated, except for IL-6, which was down-regulated, with a
FC = -2.32 (p-value = 0.007) (Table 1).
Discussion
In the current study, we compared the gene expression profiles of whole blood sampled from
cattle before and during infection, at the beginning of clinical signs of acute CBPP.
Fig 3. Top functions related to immune response differentially expressed in whole blood ofMmm-infected cattle. The ten most modulated top
functions related to immune response were categorized by Ingenuity Pathway Analysis software according to p-values and z-scores. The number of
differentially expressed genes in each top function is given.
doi:10.1371/journal.pone.0139678.g003
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Table 2. IPA top functions and corresponding bio-functions up- or down-regulated byMmm infection.
Top functions, bio-functions and modulated genes p-Value z-score genes predicted
Organismal survival
Organismal death ABCC1, ACTG1, ACVR1, ACVR2A, ADCYAP1R1, ADM, AFF4, AGTR1, AHI1, ANGPT1,
ANP32E, APAF1, APH1A, APLP2, ARNT, ATP6AP1, B4GALT1, BAG6, BARD1, BIRC6, BUB1B, CASP8,
CAST, CBL, CD28, CHRNA7, Cmah, CNGB1, CNP, CR2, CREBBP, CXCR2, DAXX, DBT, DLG1,
DMTF1, DNMT3A, DYRK1A, E2F4, EHD1, EHHADH, EIF2AK3, ERCC8, F5, FUT8, FYN, G2E3, GATA6,
GNAO1, GUCY1B3, HDAC8, HTR2B, HUWE1, ICOS, IFT57, IKZF1, IKZF2, IL1B, IL1R1, IL1RL1, IL1RN,
ILK, INSR, IRF2, IVNS1ABP, KCNAB2, KDM6A, KIF1B, KRT19, LAMA4, LAT2, LATS1, LIN9, LRRK2,
LYN, MAP3K4, MAP3K7, MCM3AP, MDM4, MED23, MED24, MEF2A, MIB1, MLL, MSH3, MTMR2,
MTTP, MYCBP2, MYD88, NAB2, NBN, NCOA1, NEDD4, NFAT5, NFE2L1, PARP1, PCDHGC5, PDE4B,
PDHA1, PHF14, PIP5K1C, PLAU, PLCL1, PLOD3, POR, PTAFR, PTPN11, PTPN6, PTPRC, RAC2,
RAD50, RAD54B, RBL1, RBP2, RUNX2, SERPINC1, SF3B1, SHOC2, SIRT7, SKI, SLC20A1, SMAD5,
SNX13, SOX5, SPEN, SPTBN1, SQSTM1, SREBF2, STAT4, STIM2, SYNE1, SYNE2, SYNJ1, TBK1,
TERF2, TGM2, TOP2B, TOPBP1, UBA6, UBE3A, UBR2, USF1, USP14, VAV3, VCL, VHL, VPRBP,
WASL, XRCC5, ZFPM2, ZFR
2.46.10−3 6.30 151 UP
Cell death and survival
Cell viability of ﬁbroblasts ABCC1, E2F4, EIF2AK3, FANCC, INSR, NBN, PARP1, PTPN11, XRCC5 6.8.10−3 -2.433 9 DOWN
Cell survival ABCC1, ABCC6, ABCG2, ACVR2A, ALKBH8, ANGPT1, ANLN, APAF1, ASCC3, ATG3,
ATRX, BARD1, BIRC6, BUB1B, CA2, CASP8, CBL, CD28, CREBBP, DAXX, DCK, DPP3, DPP8, DST,
DUSP6, E2F4, EEF2, EFNA1, EIF2AK3, FANCC, FYN, GALNT3, GATA6, HERPUD1, HSPBAP1, ICOS,
IKZF2, IL1B, IL1RN, IL7R, ILK, INSR, KIF1B, KRT19, LRRK2, LYN, MALT1, MAP3K4, MAP3K7, MSH3,
MYD88, NBN, NFAT5, NTN4, OGT, PARP1, PCDHGC5, PDHA1, PLAU, PLSCR1, POR, PPEF2,
PPP1R8, PPP2R3A, PTAFR, PTPN11, PTPN6, PTPRC, PTPRO, RAC2, RAD50, RBBP4, SHPRH,
SQSTM1, SREBF2, SSPN, STAT4, TAF4B, TBK1, TGM2, THPO, TOPBP1, USP14, VCL, VHL, XRCC5
1.89.10−2 -2.134 86 DOWN
Hematological system development and function
Quantity of hematopoietic progenitor cells CASP8, CBL, CD28, CHRNA7, CREBBP, DCK, DMTF1,
E2F4, EPB42, FANCC, FYN, GRAP2, HIVEP2, IKZF1, IL1RL1, IL7R, LAMA4, LYN, MLL, MYD88, NBN,
PTPN11, PTPN6, PTPRC, RAC2, RASGRP1, RUNX2, SLC20A1, SMAD5, STAT4, THEMIS, THPO,
TXK, VAV3, VHL, WASL, XRCC5
1.16.10−2 -3.431 37 DOWN
Quantity of leukocytes ABCG2, B4GALT1, CASP8, CBL, CD28, CHRNA7, Cmah, CNR2, CR2, CREBBP,
CTSS, CXCR2, CXCR5, DCK, DMTF1, E2F4, ELMO1, FANCC, FYN, GCNT1, GRAP2, HIVEP2, ICOS,
IKZF1, IL10RA, IL1B, IL1R1, IL1RL1, IL1RN, IL7R, IRF2, LYN, MALT1, MAP3K7, MDM4, MLL, MYD88,
MYO9B, NBN, NFAT5, PDE4B, PLAU, PLSCR1, PTPN11, PTPN6, PTPRC, RAC2, RASGRP1, RUNX2,
SIRT7, SLA, SLC20A1, STAT4, TBK1, TGM2, THEMIS, THPO, TNFRSF21, TXK, VAV3, WASL, XRCC5
3.17.10–2 -3.051 62 DOWN
Quantity of lymphocytes ABCG2, B4GALT1, CASP8, CBL, CD28, CHRNA7, Cmah, CNR2, CR2,
CREBBP, CTSS, CXCR2, CXCR5, DCK, DMTF1, E2F4, FANCC, FYN, GCNT1, GRAP2, HIVEP2, ICOS,
IKZF1, IL10RA, IL1R1, IL1RL1, IL7R, IRF2, LYN, MALT1, MAP3K7, MYD88, NBN, NFAT5, PLAU,
PTPN6, PTPRC, RAC2, RASGRP1, RUNX2, SLA, STAT4, TBK1, THEMIS, TNFRSF21, TXK, VAV3,
WASL, XRCC5
1.82.10–2 -2.787 49 DOWN
Quantity of B lymphocytes CD28, Cmah, CNR2, CR2, CREBBP, CXCR2, CXCR5, DCK, FYN, ICOS,
IKZF1, IL1RL1, IL7R, IRF2, LYN, MALT1, MAP3K7, NBN, PTPN6, PTPRC, RAC2, RASGRP1, RUNX2,
SLA, VAV3, WASL
1.22.10–2 -2.428 26 DOWN
Function of lymphocytes CBL, CD28, Cmah, CNR2, CR2, CTSS, CXCR2, DLG1, DMTF1, FYN, ICOS,
IL10RA, IL16, IL1B, IL1RL1, LAT2, LYN, MAP3K4, MYD88, PANX1, PTPRC, RAD50, RASGRP1, STAT4,
TBK1, TGM2, TNFRSF21, TXK
1.19.10–3 -2.408 28 DOWN
Function of T lymphocytes CBL, CD28, Cmah, CTSS, CXCR2, DLG1, DMTF1, FYN, ICOS, IL10RA, IL16,
IL1RL1, LAT2, MAP3K4, MYD88, PANX1, PTPRC, RAD50, RASGRP1, STAT4, TBK1, TGM2,
TNFRSF21, TXK
8.37.10–4 -2.395 24 DOWN
Quantity of myeloid progenitor cells CASP8, CREBBP, FANCC, IL1RL1, MLL, SLC20A1, THPO 5.27.10–3 -2.213 7 DOWN
Quantity of erythroid progenitor cells CHRNA7, CREBBP, DCK, E2F4, EPB42, IKZF1, IL1RL1, LAMA4,
LYN, PTPN6, RAC2, SLC20A1, SMAD5, THPO, VHL
1.45.10–2 -2.128* 15 DOWN
Homing of lymphocytes ANGPT1, B4GALT1, CD28, CNR2, CXCR2, CXCR5, FLOT1, FYN, GCNT1,
GNAO1, HEBP1, IL16, IL1B, IL1R1, ITGA1, LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU,
PTPN6, PTPRC, PTPRO, RAC2, SERPINC1, WASL
6.57.10–3 2.995* 28 UP
Chemotaxis of myeloid cells ANGPT1, B4GALT1, CD28, CXCR2, FLOT1, HEBP1, IL1B, IL1R1, ITGA1,
LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU, PTPN6, PTPRC, PTPRO, RAC2, SERPINC1
3.94.10–2 2.812* 21 UP
Activation of NK cells BLOC1S6, CD28, IL1B, IL1RL1, IL1RN, KLRF1, MALT1, MYD88, STAT4 3.08.10–2 2.39* 9 UP
(Continued)
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Table 2. (Continued)
Top functions, bio-functions and modulated genes p-Value z-score genes predicted
Chemotaxis of phagocytes ANGPT1, B4GALT1, CD28, CXCR2, FLOT1, FYN, HEBP1, IL16, IL1B, IL1R1,
ITGA1, LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU, PTPN6, PTPRO, RAC2, SERPINC1
2.61.10–2 3.015* 22 UP
Recruitment of antigen presenting cells B4GALT1, CNR2, CXCR2, FUT8, IL1B, IL1RN, LYN, MYD88 2.88.10–2 2.734* 8 UP
Cell morphology
Morphology of lymphocytes CD28, CD46, CR2, CREBBP, DCK, FANCC, FYN, GRAP2, HIVEP2, IKZF1,
IL1RN, IL7R, LYN, MALT1, PTPRC, SLA, THEMIS, XRCC5
1.57.10–4 2.37 18 UP
Morphology of blood cells B4GALT1, CD28, CD46, CR2, CREBBP, CXCR5, DCK, E2F4, EPB42, FANCC,
FYN, GCNT1, GRAP2, HIVEP2, IKZF1, IL1RN, IL7R, LYN, MALT1, MLL, PTPRC, RAD54B, RBL1,
S1PR4, SLA, THEMIS, THPO, XRCC5
5.98.10–3 2.154 28 UP
Morphology of leukocytes CD28, CD46, CR2, CREBBP, CXCR5, DCK, E2F4, FANCC, FYN, GCNT1,
GRAP2, HIVEP2, IKZF1, IL1RN, IL7R, LYN, MALT1, PTPRC, RBL1, SLA, THEMIS, XRCC5
2.29.10–2 2.154 22 UP
Hematopoiesis
Quantity of hematopoietic progenitor cells CASP8, CBL, CD28, CHRNA7, CREBBP, DCK, DMTF1,
E2F4, EPB42, FANCC, FYN, GRAP2, HIVEP2, IKZF1, IL1RL1, IL7R, LAMA4, LYN, MLL, MYD88, NBN,
PTPN11, PTPN6, PTPRC, RAC2, RASGRP1, RUNX2, SLC20A1, SMAD5, STAT4, THEMIS, THPO,
TXK, VAV3, VHL, WASL, XRCC5
1.16.10−2 -3.431 37 DOWN
Quantity of myeloid progenitor cells CASP8, CREBBP, FANCC, IL1RL1, MLL, SLC20A1, THPO 5.27.10−3 -2.213 7 DOWN
Quantity of erythroid progenitor cells CHRNA7, CREBBP, DCK, E2F4, EPB42, IKZF1, IL1RL1, LAMA4,
LYN, PTPN6, RAC2, SLC20A1, SMAD5, THPO, VHL
1.45.10−2 -2.128* 15 DOWN
Tissue morphology
Quantity of hematopoietic progenitor cells CASP8, CBL, CD28, CHRNA7, CREBBP, DCK, DMTF1,
E2F4, EPB42, FANCC, FYN, GRAP2, HIVEP2, IKZF1, IL1RL1, IL7R, LAMA4, LYN, MLL, MYD88, NBN,
PTPN11, PTPN6, PTPRC, RAC2, RASGRP1, RUNX2, SLC20A1, SMAD5, STAT4, THEMIS, THPO, TXK,
VAV3, VHL, WASL, XRCC5
1.16.10−2 -3.431 37 DOWN
Quantity of leukocytes ABCG2, B4GALT1, CASP8, CBL, CD28, CHRNA7, Cmah, CNR2, CR2, CREBBP,
CTSS, CXCR2, CXCR5, DCK, DMTF1, E2F4, ELMO1, FANCC, FYN, GCNT1, GRAP2, HIVEP2, ICOS,
IKZF1, IL10RA, IL1B, IL1R1, IL1RL1, IL1RN, IL7R, IRF2, LYN, MALT1, MAP3K7, MDM4, MLL, MYD88,
MYO9B, NBN, NFAT5, PDE4B, PLAU, PLSCR1, PTPN11, PTPN6, PTPRC, RAC2, RASGRP1, RUNX2,
SIRT7, SLA, SLC20A1, STAT4, TBK1, TGM2, THEMIS, THPO, TNFRSF21, TXK, VAV3, WASL, XRCC5
3.17.10−2 -3.051 62 DOWN
Lymphoid tissue structure and development
Quantity of lymphatic system cells ABCG2, CASP8, Cmah, CNR2, CR2, CREBBP, FANCC, ICOS, IKZF1,
IL1RL1, IL7R, ITGA1, LYN, MAP3K7, MDM4, MLL, MYD88, RBL1, SLC20A1, THPO, VHL, WASL
2.92.10−2 -2.575 22 DOWN
Quantity of myeloid progenitor cells CASP8, CREBBP, FANCC, IL1RL1, MLL, SLC20A1, THPO 5.27.10−3 -2.213 7 DOWN
Cell to cell signaling and interactions
Recruitment of antigen presenting cells B4GALT1, CNR2, CXCR2, FUT8, IL1B, IL1RN, LYN, MYD88 2.88.10−2 2.734* 8 UP
Activation of NK cells BLOC1S6, CD28, IL1B, IL1RL1, IL1RN, KLRF1, MALT1, MYD88, STAT4 3.08.10−2 2.39* 9 UP
Immune cell trafﬁcking
Homing of leukocytes ANGPT1, B4GALT1, CD28, CNR2, CXCR2, CXCR5, FLOT1, FYN, GCNT1,
GNAO1, HEBP1, IL16, IL1B, IL1R1, ITGA1, LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU,
PTPN6, PTPRC, PTPRO, RAC2, SERPINC1, WASL
6.57.10−3 2.995* 28 UP
Chemotaxis of myeloid cells ANGPT1, B4GALT1, CD28, CXCR2, FLOT1, HEBP1, IL1B, IL1R1, ITGA1,
LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU, PTPN6, PTPRC, PTPRO, RAC2, SERPINC1
3.94.10−2 2.812* 21 UP
Activation of NK cells BLOC1S6, CD28, IL1B, IL1RL1, IL1RN, KLRF1, MALT1, MYD88, STAT4 3.08.10−2 2.39* 9 UP
Chemotaxis of phagocytes ANGPT1, B4GALT1, CD28, CXCR2, FLOT1, FYN, HEBP1, IL16, IL1B, IL1R1,
ITGA1, LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU, PTPN6, PTPRO, RAC2, SERPINC1
2.61.10−2 3.015* 22 UP
Recruitment of antigen presenting cells B4GALT1, CNR2, CXCR2, FUT8, IL1B, IL1RN, LYN, MYD88 2.88.10−2 2.734* 8 UP
Cellular movement
Recruitment of antigen presenting cells B4GALT1, CNR2, CXCR2, FUT8, IL1B, IL1RN, LYN, MYD88 2.88.10−2 2.734* 8 UP
Chemotaxis of phagocytes ANGPT1, B4GALT1, CD28, CXCR2, FLOT1, FYN, HEBP1, IL16, IL1B, IL1R1,
ITGA1, LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU, PTPN6, PTPRO, RAC2, SERPINC1
2.61.10−2 3.015* 22 UP
Chemotaxis of myeloid cells ANGPT1, B4GALT1, CD28, CXCR2, FLOT1, HEBP1, IL1B, IL1R1, ITGA1,
LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU, PTPN6, PTPRC, PTPRO, RAC2, SERPINC1
3.94.10−2 2.812* 21 UP
(Continued)
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Tempus technology is a relevant and practical approach for whole blood
transcriptome analyses in cattle
Several human studies have shown that, during pulmonary infection, local interaction between
the infectious agent or its products and infiltrated immune cells is followed by changes in the
gene expression profile of these cells, which re-circulate in whole blood [21] and express a sig-
nature of their exposure to the pathogen [22]. Global changes in gene expression in blood are a
reflection of the immune response developed by the host when encountering the pathogen
[23]. We decided to use this approach to explore the dynamic characterization of host-patho-
gen interactions in CBPP, starting by characterizing the bovine response toMmm infection
during acute disease, at the first appearance of clinical signs.
Peripheral whole blood is easy to collect for differential gene expression studies but it is well
established that sample collection and purification greatly influence RNA quality and tran-
script stability [24,25]. Sheridan et al. [26] showed that a delay between collecting whole blood
from cattle and extracting and processing of RNA could significantly alter gene expression pro-
files and that the magnitude of the fold-change was consistent with the length of the delay [27].
They recommended the use of TempusTM collection tubes for the stabilization of mRNA tran-
scripts. The use of whole blood collected in RNA stabilizing reagents is currently recognized as
the most reproducible method with the least variability between individuals and the minimum
bias in gene expression in leukocyte cellular functions [28]. In our study, use of TempusTM
technology resulted in a satisfactory quantity and quality of RNA, although samples from
healthy animals had lower RIN values than those from infected animals (6.9 ± 0.4 versus
8.5 ± 0.1). This may be due to a longer interval between sampling and processing (approxi-
mately 20 weeks longer than for samples from infected animals). In conclusion, TempusTM
technology proved to be a very practical way of stabilizing RNA in the field, while providing
remarkable results in terms of quantity and quality of RNA for transcriptional profiling.
Whole blood transcriptome analysis of Mmm-infected cattle reveals
immunological disorders
Analysis of gene expression profiles in blood during acute CBPP revealed 680 regulated genes,
with many more down-regulated genes (544, i.e. 80%) than up-regulated genes (136, i.e. 20%).
It is important to note that previous ex vivo systemic cellular immune response studies showed
neither variations in cell numeration nor significant changes in cell subsets during the disease
[10], indicating that this major down-regulation was not a bias due to a drop in the number of
Table 2. (Continued)
Top functions, bio-functions and modulated genes p-Value z-score genes predicted
Homing of leukocytes ANGPT1, B4GALT1, CD28, CNR2, CXCR2, CXCR5, FLOT1, FYN, GCNT1,
GNAO1, HEBP1, IL16, IL1B, IL1R1, ITGA1, LRRK2, LYN, MYD88, MYO9B, PDE4B, PIP5K1C, PLAU,
PTPN6, PTPRC, PTPRO, RAC2, SERPINC1, WASL
6.57.10−3 2.995* 28 UP
Homing ABCC1, AGTR1, ANGPT1, B4GALT1, CBL, CD28, CNR2, CXCR2, CXCR5, DUSP6, EFNA1,
FLOT1, FYN, GCNT1, GNAO1, HEBP1, IL16, IL1B, IL1R1, ILK, ITGA1, LRRK2, LYN, MYD88, MYO9B,
NEDD4, PDE4B, PIP5K1C, PLAU, PTAFR, PTPN11, PTPN6, PTPRC, PTPRO, RAC2, SEMA3B,
SERPINC1, USP14, WASL
2.57.10−2 2.106* 39 UP
p-values were calculated with the Fisher exact test. Z-scores were calculated with the IPA z-score algorithm. The z-score predicts the direction of change
of a function. An absolute z-score  2 was considered to be signiﬁcant. A bias-corrected z-score* was calculated by IPA to correct dataset bias, i.e., when
there are more up- than down-regulated genes or vice-versa. “genes” indicates the number of genes that are associated with each function. A function is
predicted to be decreased (DOWN) if the z-score (or the bias corrected z-score)  2 and increased (UP) if the z-score2.
doi:10.1371/journal.pone.0139678.t002
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total leukocytes or to modification of their relative abundance in the blood of infected cattle.
Several studies on bovine tuberculosis also reported more down- than up-regulated genes ([29]
[30], [31]). Even if the pathogenic mechanisms ofMycobacterium tuberculosis are probably dif-
ferent, the overwhelming majority of down-regulated genes in this study suggests pathogen-
induced immunosuppression, which is consistent with our previous findings. Indeed, in vitro
immunological studies showed that acute infection was characterized by a lowMmm-specific
immune response, with low CD4+ T-cell recall responses and low or absent IFNγ production,
in direct opposition to what was observed in chronic disease and recovered animals. [10,11].
Our results confirm that immunosuppression is a characteristic of the acute form of CBPP.
In the present study, gene modulation analysis identified an increase in the organismal
death bio-function, with 151 regulated molecules and a decrease in cell survival bio-function,
with 86 affected molecules (Table 2). These results do not only reflect the severe clinical signs
observed in these animals during acute disease, but are also consistent with the results of previ-
ous in vitro analyses, showing that viableMmm caused programed cell death of leukocytes [8].
This previous study also revealed that the observed effects were induced byMmm-secreted
components, suggesting thatMmm has developed mechanisms to modulate the host immune
response based on secreted factors, as reviewed by Pilo et al. [32]. Although mycoplasmemia
duringMmm infection is only transitory, this free exopolysaccharide can be detected in blood
throughout the course of the clinical disease [3] and has been shown to play a role inMmm
persistence and dissemination by increasing resistance to active oxygen species secreted either
byMmm itself or by immune cells [7].
Other highlighted affected top functions concerned cell morphology, hematological system
development and hematopoiesis, lymphoid tissue structure and development and tissue morphol-
ogy, which were generally reduced inMmm-infected animals. Some genes modulated in the
present study are components of immune response pathways, or are involved in the regulation
of these pathways and belong to the “common host-response to pathogens” described by Jen-
ner and Young [33]. Indeed, reviewing numerous host-pathogen interaction microarray stud-
ies, the authors showed that a common host response exists, with common functional groups
of modulated genes, representative of a general alarm signal for infection [33]. This modulated
gene set has been shown to be reprogrammed by each specific pathogen and Ramilo et al. sug-
gest that the final global signature in the host caused by different etiologic agents is specific
[22]. Despite similarities between immune responses against pathogens, Boldrick et al. suggest
that bacteria induce stereotyped and specific gene expression modulation [34] and Jenner and
Young suggest that there is a preferential induction of genes in specific cell types and specific
reprogramming of host cells by pathogens [33]. Therefore, the modulation of many of these
genes involved in immune bio-functions does not represent a specific response toMmm infec-
tion, since they form part of the “common host response” to pathogens, though at least part of
this response may be reprogrammed byMmm in a specific manner.
Finally, we identified a third group of up-regulated immune top functions, grouping cellular
movement, cell to cell signaling and immune cell trafficking. These functions included recruit-
ment of antigen presenting cells, chemotaxis of phagocytes and myeloid cells, homing of leuko-
cytes and activation of NK-cells. We hypothesize that these activated NK-cells could be
involved in the production of INFɣ detected in the plasma ofMmm-infected animals [35].
Several particular genes that were significantly modulated in our study are key compo-
nents of the immune response pathways. MyD88, a gene that plays a central role in the innate
and adaptive immune response (common host response), was up-regulated (FC 3.202; p-
value 0.048) in infected cattle. The protein encoded by MyD88 functions as a signal trans-
ducer in IL-1 and TLR pathways, leading to NF-KB activation, cytokine secretion and inflam-
mation. This is in agreement with the fact that acute CBPP is characterized by significant
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pulmonary inflammation, which causes severe clinical signs and extensive lesions. On the
other hand, CD28, a gene involved in several of the modulated immune functions we identi-
fied, was down-regulated in our study (FC -2.72; p-value 0.0198). CD28 is a resting T-cell
surface protein and binds to antigen presenting cells via CD80/CD86 molecules. In associa-
tion with MHC, it enables T-cell activation and proliferation. Consequently, in the absence
of signaling through CD28, an incomplete T-cell response occurs leading to tolerance or
anergy [36]. Impaired signaling through CD28 is consistent with results of previous in vitro
studies showing that pre-incubation ofMmm with T-cells followed by non-specific mito-
genic stimulation led to a significant depression of lymphocyte responsiveness to the mitogen
Concanavalin A [9,13]. Thus, modulation of CD28 expression by liveMmm deserves further
investigation, as it may be a new more subtle mechanism than programed cell death to sup-
press the host immune response.
Whole blood transcriptome analysis does not reflect local inflammation
Interestingly, genes involved in inflammation mechanisms were not shown modulated dur-
ing infection, whereas pulmonary inflammation is the most characteristic trait of acute
CBPP. Gene expression of pro-inflammatory cytokines such as the TNF superfamily, Inter-
leukin 6, Interleukin 1, or Interleukin 12, as well as the TLR family genes, was not differen-
tially modified inMmm-infected animals. The RT-qPCR exploration of pro-inflammatory
cytokines (TNFα, TLR2, IL-12B and IL-6) confirmed this lack of regulation, except for IL-6,
which was statistically down-regulated. Specific exploration of a few modulated genes
involved in inflammatory response (IL-1RN; IL-10RA; CXCR2 and MyD88) revealed contra-
dictory responses, indicating complex modulation of inflammation in blood [37,38,39,40].
The fact that the local inflammatory response that characterizes acute CBPP was not
reflected in whole blood in this study was surprising and differs from other studies in human
pneumonia, where inflammatory cytokines [41] or genes related to inflammation were
detected in blood as well as in lung [42]. On the contrary, as in our study, inflammation was
not up-regulated in blood in human tuberculosis and sarcoidosis [43,44]. This may be due
either to high dilution of inflammatory cells in the circulation, possibly due to sequestration
of immune cells in inflamed lymph nodes, or to circulation ofMmm-secreted products with
anti-inflammatory properties. TheMmm polysaccharide galactan, which can be detected in
the blood of infected animals during clinical disease, particularly focuses our attention. Pre-
liminary in vitro analysis using highly purified galactan [45] suggests a potent anti-inflam-
matory effect on bovine macrophages (P. Totte, personal communication). Another
potential reason to explain the absence of inflammation-related transcripts in blood may be
that resident lung cells, such as non-trafficking immune cells or epithelial/endothelial cells,
are responsible for the local inflammation. This hypothesis is in agreement with the findings
of Sacchini et al, who showed that TNFα was increased in blood of CBPP-infected cattle,
although plasma levels did not increase dramatically in acute CBPP. The authors suggested
that TNFαmay be produced locally, then re-circulate [35].
Whole blood transcriptome analysis clearly differentiates Mmm-infected
from non-infected cattle
An interesting aspect of our results was that investigations of whole blood gene expression and
hierarchical clustering analysis of differentially expressed entities clearly differentiated Mmm-
infected animals from non-infected ones. We therefore suggest thatMmm produces a response
in the blood of infected animals that is a signature of its exposure to the pathogen. In other dis-
eases, including tuberculosis, gene expression analysis in whole blood provides valuable
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information for diagnostic or prognostic purposes. [29,30,46]. Transcriptional profiles of latent
and cured tuberculosis patients were found to be different from those of patients with active
tuberculosis and a gene set was identified to determine the form of the disease or to predict its
severity [46]. Similarly, in our study, we identified 1,115 entities as anMmm infection signature
that would enable infected animals to be distinguished from healthy animals at the beginning
of the clinical signs. This constitutes a global signature allowing the statistical discrimination of
infected animals at a particular phase of the disease, though it was not possible to obtain a
more limited set of regulated genes with such a signature value specific for CBPP at this stage.
Conclusion
This work aimed to assess the use of whole blood transcriptome profiling to study bovine-
mycoplasma interactions in order to explore the dynamic characterization of host-pathogen
interactions in CBPP. For this preliminary study, it was decided to start by the characterization
of the bovine response toMmm infection during acute disease. Our results represent a “time-
point picture” of the immune events occurring in the cattle-Mmm interplay at the appearance
of the clinical signs. This global picture should be considered as the result, in blood, of the local
pulmonary response (e.g. apoptosis) and the systemic events (e.g. potent anti-inflammatory
properties of circulating galactan) occurring during acuteMmm infection. We showed that the
expression of many genes was modulated, with an overwhelming majority of down-regulation
of gene expression inducing an immunosuppression with consequences for important immune
functions. Nevertheless, to understand the detailed immune events occurring during the dis-
ease, specific analyses of the different immune cell subpopulations, either in vivo, at the local
site, or in vitro, are required. Furthermore, as our results represent a single time-point in the
kinetics of acute CBPP, further work is needed to implement this approach throughout the
course of the disease, which should enable the identification of molecular signatures associated
with the different stages and forms of the disease. The availability of bio-signatures correlating
to recovery and protection would be of particular interest, since they should facilitate the devel-
opment and validation of novel vaccine formulations, avoiding costly and laborious experi-
mental challenges in cattle.
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